T., Arauz-Pacheco, C., et al
Gene and protein delivery platforms Nanocarrier-enabled delivery of macromolecules, including genes, small interfering RNAs (siRNAs), and proteins, represents a paradigm shift in GLP-1R-targeted therapy, providing prolonged or programmable effects that outperform conventional small-molecule approaches in duration, precision, and disease specificity [213, 425, 426]
Hyperthyroidism, caused by taking too much thyroid medication, may induce a state of atrial fibrillation which may result in heart palpitations
Exenatide and sitagliptin are not associated with increased risk of acute renal failure: a retrospective claims analysis